Tag Archives: CapLaw-2020-42

Placement of New Shares of Molecular Partners

On 7 July 2020, Molecular Partners announced the placement of 5’528’089 new shares to institutional investors by way of an accelerated book-building process in a private placement. The offer price was set at CHF 14.50 per share. The gross proceeds from the placement amounted to CHF 80.2 million. The proceeds from the capital increase will be used to fund research & development activities as well as for general corporate purposes.